Medicale Corp.

MCLE

US58464K1025

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 11:20:47 01/07/2024 pm IST			5-day change	1st Jan Change
0.33 ^USD	+22.22%		+484.07%	+120.00%

14/05	Medicale Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
15/02	Medicale Corp Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

Medicale Corp Reports Earnings Results for the Full Year Ended September 30, 2023

January 02, 2024 at 06:30 pm IST

Medicale Corp reported earnings results for the full year ended September 30, 2023. For the full year, the company reported net loss was USD 0.037138 million compared to USD 0.046419 million a year ago. Basic loss per share was USD 0.01 compared to USD 0.01 a year ago.

Latest news about Medicale Corp.

Medicale Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	14/05	CI
Medicale Corp Reports Earnings Results for the First Quarter Ended December 31, 2023	15/02	CI
Medicale Corp Reports Earnings Results for the Full Year Ended September 30, 2023	02/01	CI
Medicale Corp Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	15/23/15	CI
Medicale Corp Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	22/23/22	CI

Chart Medicale Corp.

Duration

Period

More charts

Company Profile

Medicale Corp. intends to offer consulting services and distribution of the dietary supplements. The dietary supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid. The supplement can provide nutrients either extracted from food sources or synthetic, individually or in combination, to enhance the quantity of their consumption. The Company has not commenced any operations.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
MEDICALE CORP.	+120.00%	19.54L
MCKESSON CORPORATION	+26.32%	7.61TCr
CARDINAL HEALTH, INC.	-4.23%	2.38TCr
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+15.24%	880.49Cr
SINOPHARM GROUP CO. LTD.	+1.71%	828.85Cr
HUADONG MEDICINE CO., LTD	-33.21%	676.62Cr
H. LUNDBECK A/S	+19.66%	535.53Cr
GALENICA AG	+0.89%	405.73Cr
EBOS GROUP LIMITED	-8.73%	377.01Cr
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-9.28%	338.56Cr